Markers of HTLV-III in patients with end stage renal failure treated by haemodialysis.

Michel Goldman, Corinne Liesnard, J L Vanherweghem, Nicole Dollé, C. Toussaint, S Sprecher, Jacqueline Cogniaux, L Thiry

BMJ · 1986 · 27 citations · 5 references

DOIFull text

Open access

Concepts

Abstract

Patients and members of staff from a haemodialysis unit were tested for markers of infection with human T cell lymphotropic virus type III (HTLV-III), the virus associated with the acquired immune deficiency syndrome (AIDS). An enzyme linked immunosorbent assay showed eight of 100 patients to have antibodies to HTLV-III. In five of these patients past or present infection with HTLV-III was confirmed by Western blot analysis or detection of HTLV-III antigens in lymphocyte cultures, or both. Investigation of other risk factors for AIDS showed that the putative source of HTLV-III was unrelated to dialysis in two patients whereas blood transfusion was the most likely cause of contamination in the others. No member of staff gave a positive result in the enzyme linked immunosorbent assay. Nosocomial transmission of HTLV-III seems unlikely if precautions similar to those recommended for the control of hepatitis B infection are applied.

References

5